CAMPBELL, Calif., March 28, 2019 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, today announces more than 30 healthcare solution companies are building the next wave of connected wearable healthcare solutions on its new IoT Medical Wearable Sensor Platform. Available through the VivaLNK Developer Program, VivaLNK is the first to provide an integrated IoT medical sensor software development kit (SDK) for healthcare application developers to access various sensors and data integration options, thereby minimizing the need to source from multiple vendors for a complete solution.
VivaLNK’s Sensor Platform is seeing global adoption with partners in more than ten countries, including Australia, Canada, Chile, China, Finland, Germany, Japan, Taiwan, U.K., and the U.S. The unique Sensor Platform captures human vitals and biometrics and delivers data from the patient to the edge or the cloud for application integration and analysis.
The company’s wearable sensors, based on its eSkin™ technology, include reusable temperature and electrocardiogram (ECG) patches to continuously stream ECG rhythm, heart rate, RR-interval, temperature, and three-axis accelerometer data, with additional sensor data planned for the future.
Healthcare applications using the VivaLNK Sensor Platform is nearly unlimited, and include:
AiCare, a company that successfully started in Japan and is now serving the U.S. and Taiwan markets, offers personalized health monitoring solutions such as real-time activity analysis, location tracking, and health monitoring for residents of nursing care facilities.
“VivaLNK’s medical wearable sensors provide a real-time, continuous stream of human vitals that can easily be integrated into AiCare’s monitoring application,” said Sean Tan, CEO of AiCare. “The small and comfortable form factor helps ensure user adoption, and it’s reusability makes it economical.”
Cardiolyse, headquartered in Finland, offers a unique ECG based assessment aimed at understanding cardiovascular health in order to promote longer and healthier lives.
“VivaLNK’s medical wearable sensors are unique given the reusable form factor, ease of use, and continuous data stream,” said Anna Starynska, CEO at Cardiolyse. “This enables us to capture a more complete picture of one’s health over a longer period of time.
Cheerslife Technology, based in China, is a provider of solutions for nursing applications that improve the patient experience, and increase the efficiency of nursing management.
“VivaLNK’s flexible wearable sensors deliver vital information in a timely and accurate manner to our smart care systems within our existing hospitals and nursing homes,” said Fred Gu, CEO of Cheerslife. “Our customers feel VivaLNK’s products are comfortable to wear and easy to operate, greatly improving the efficiency of care.”
For information about the Developer Program visit: https://www.vivalnk.com/developer/
For information about the Sensor Platform visit: https://www.vivalnk.com/products/platform
About VivaLNK
VivaLNK is a provider of connected healthcare solutions for wellness, patient care, and telemedicine. The company’s portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals. The company’s vision is to improve the quality and accessibility of healthcare worldwide by combining technology, data, and analytics into an integrated solution.
Media Contact:
pr@VivaLNK.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/vivalnk-iot-medical-sensor-platform-sees-worldwide-impact-with-more-than-30-partners-advancing-remote-patient-monitoring-300820131.html
SOURCE VivaLNK
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…